Editor's Note: Green and red arrows refer to intraday stock price movement.
NEW YORK (
STOCK COMMENTS / EPS CHANGES
estimates, target increased at Jefferies. A estimates were raised through 2012, Jefferies said. Company is delivering higher organic growth and generating solid cash flow. Buy rating.
estimates, target raised at Morgan Stanley. Shares of APA now seen reaching $150, according to Morgan Stanley. Estimates also increased, as the company is positioned well for growth in 2012. Overweight rating.
estimates, target boosted at Goldman. Shares of DAR now seen reaching $20, according to Goldman Sachs. Estimates also upped, as the company is seeing better pricing. Buy rating.
estimates, target reduced at Goldman. Shares of DRYS now seen reaching $5.50, according to Goldman Sachs. Estimates also cut, as the company is facing higher expenses and a higher share count. Neutral rating.
numbers raised at Jefferies. Shares of FRX now seen reaching $42, according to Jefferies. Estimates also increased, given expectations for a solid launch of Daliresp. Buy rating.
estimates lowered at UBS through 2012. Checks show lower television and national print advertising demand. Neutral rating and $16 price target.
estimates, target boosted at Argus. Shares of MA now seen reaching $325, according to Argus Research. Estimates also upped. Buy rating.
estimates, target upped at Goldman. MRK estimates were boosted through 2015, Goldman Sachs said. New hepatitis treatment will add to earnings. Neutral rating and new $40 price target.
target increased at Morgan Stanley to $70. Company is seeing better demand across the board. Overweight rating.
End of report.
This article was written by a staff member of TheStreet.